Results 21 to 30 of about 9,036 (151)

Tackling the blind spot of poor-quality medicines in Universal Health Coverage

open access: yesJournal of Pharmaceutical Policy and Practice, 2020
Background Universal Health Coverage (UHC) is challenged by the prevalence of poor-quality medicines, those that either do not meet required specifications (substandard) or are outrightly fraudulent (falsified), especially in Low- and Middle-Income ...
E. S. F. Orubu   +3 more
doaj   +1 more source

Environmental DNA as an innovative technique to identify the origins of falsified antimalarial tablets—a pilot study of the pharmabiome

open access: yesScientific Reports, 2022
Falsified medicines are a major threat to global health. Antimalarial drugs have been particularly targeted by criminals. As DNA analysis has revolutionized forensic criminology, we hypothesized that these techniques could also be used to investigate the
Jennifer M. Young   +8 more
doaj   +1 more source

Emerging Antimicrobial Drug Resistance in Africa and Latin America: Search for Reasons

open access: yesRisk Management and Healthcare Policy, 2022
Ludwig Hoellein,1 Eliangiringa Kaale,2 Yonah Hebron Mwalwisi,3 Marco H Schulze,4 Carina Vetye-Maler,5 Ulrike Holzgrabe1 1Institute for Pharmacy and Food Chemistry, Julius-Maximilians-Universität Würzburg, Würzburg, Germany; 2Muhimbili University of ...
Hoellein L   +5 more
doaj  

The scourge of substandard and falsified medical products gets worse with COVID-19 pandemic

open access: yesThe Pan African Medical Journal, 2020
Although health professionals, communities, governments and global institutions work closely to halt the spread of COVID-19 and mitigate its societal impact, COVID-19 remains a challenge to many countries around the world.
Fisseha Shiferie, Eden Kassa
doaj   +1 more source

Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance

open access: yesJMIR Public Health and Surveillance, 2021
The World Health Organization and others warn that substandard and falsified medicines harm health and waste money, especially in low- and middle-income countries.
Elizabeth Pisani   +5 more
doaj   +1 more source

Introduction of Good Practices of Drug Verification (DPWL) in hospital practice in Poland in order to protect against counterfeit drugs and improve patient safety [PDF]

open access: yesFarmacja Polska, 2020
The phenomenon of counterfeit medicines is common in healthcare systems around the world, making it a global problem. The number of recorded cases of falsified drugs available on the market is increasing every year.
Piotr Merks   +2 more
doaj   +1 more source

Regulatory framework in Pakistan: situation analysis of medicine quality and future recommendations

open access: yesJournal of Pharmaceutical Policy and Practice, 2019
Background Quality issues in pharmaceuticals are identified as a huge global and public health problem, especially with reference to low- and middle-income countries like Pakistan.
Huma Rasheed   +3 more
doaj   +1 more source

A Cross-Sectional Investigation for Verification of Globalization of Falsified Medicines in Cambodia, Indicated by Tablets of Sildenafil Citrate

open access: yesPharmacy, 2019
Medicine falsification is a global issue. Viagra, an erectile dysfunction therapeutic (EDT) medicine consisting primarily of sildenafil citrate, is the most commonly falsified medicine worldwide.
Naoko Yoshida   +8 more
doaj   +1 more source

Substandard, falsified and unregistered medicines in Latin America, 2017-2018

open access: yesRevista Panamericana de Salud Pública, 2020
Objective. To assess all the incidents of substandard, falsified and unregistered medicines in 2017 and 2018 in Latin America, determining the types of products affected, stages of the supply chain in which incidents were detected, quality deviations ...
Robin Rojas-Cortés
doaj   +1 more source

Home - About - Disclaimer - Privacy